Osborn Williams & Donohoe LLC lifted its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 9.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 41,498 shares of the pharmacy operator’s stock after purchasing an additional 3,455 shares during the period. Osborn Williams & Donohoe LLC’s holdings in Walgreens Boots Alliance were worth $2,836,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in the business. Cornerstone Advisors Inc. increased its stake in Walgreens Boots Alliance by 102.4% in the third quarter. Cornerstone Advisors Inc. now owns 423 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 214 shares in the last quarter. Alpha Omega Wealth Management LLC grew its position in Walgreens Boots Alliance by 44.8% in the fourth quarter. Alpha Omega Wealth Management LLC now owns 869 shares of the pharmacy operator’s stock valued at $59,000 after purchasing an additional 269 shares in the last quarter. Central Bank & Trust Co. bought a new position in Walgreens Boots Alliance in the fourth quarter valued at $98,000. Asset Dedication LLC lifted its stake in Walgreens Boots Alliance by 204.6% in the third quarter. Asset Dedication LLC now owns 1,578 shares of the pharmacy operator’s stock valued at $115,000 after acquiring an additional 1,060 shares during the last quarter. Finally, Ipswich Investment Management Co. Inc. acquired a new stake in Walgreens Boots Alliance in the fourth quarter valued at $121,000. 63.07% of the stock is owned by hedge funds and other institutional investors.
In other Walgreens Boots Alliance news, Director Nancy M. Schlichting sold 7,050 shares of the company’s stock in a transaction dated Tuesday, November 20th. The shares were sold at an average price of $78.81, for a total transaction of $555,610.50. Following the sale, the director now directly owns 5,709 shares of the company’s stock, valued at $449,926.29. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 15.73% of the stock is currently owned by corporate insiders.
WBA has been the subject of a number of recent analyst reports. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $79.00 price target for the company in a research note on Saturday, October 13th. Pivotal Research raised their target price on shares of Walgreens Boots Alliance from $60.00 to $72.00 and gave the stock a “hold” rating in a research note on Monday, October 15th. Morgan Stanley lifted their price objective on shares of Walgreens Boots Alliance from $55.00 to $77.00 and gave the stock an “equal weight” rating in a research note on Monday, December 3rd. Goldman Sachs Group lowered shares of Walgreens Boots Alliance from a “neutral” rating to a “sell” rating in a report on Friday, December 14th. Finally, BidaskClub lowered shares of Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a report on Tuesday, December 18th. Four equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and five have given a buy rating to the company. Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus target price of $78.83.
Shares of WBA stock opened at $70.12 on Friday. The firm has a market cap of $67.17 billion, a price-to-earnings ratio of 11.65, a price-to-earnings-growth ratio of 1.11 and a beta of 0.98. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.80 and a quick ratio of 0.36. Walgreens Boots Alliance Inc has a 12 month low of $59.07 and a 12 month high of $86.31.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, December 20th. The pharmacy operator reported $1.46 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.43 by $0.03. The firm had revenue of $33.79 billion during the quarter, compared to analyst estimates of $33.90 billion. Walgreens Boots Alliance had a net margin of 3.96% and a return on equity of 22.17%. The business’s revenue was up 9.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.28 EPS. Analysts forecast that Walgreens Boots Alliance Inc will post 6.52 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 12th. Investors of record on Friday, February 15th will be given a dividend of $0.44 per share. The ex-dividend date of this dividend is Thursday, February 14th. This represents a $1.76 annualized dividend and a yield of 2.51%. Walgreens Boots Alliance’s payout ratio is currently 29.24%.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Further Reading: What is the Ex-Dividend Date in Investing?